Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Janssen Research & Development, LLC
BeOne Medicines
AstraZeneca
Dartmouth-Hitchcock Medical Center
Acerta Pharma BV
National Cancer Institute (NCI)
Acerta Pharma BV
Hoffmann-La Roche
Acerta Pharma BV
BeiGene
TG Therapeutics, Inc.
Pharmacyclics LLC.
University of Rochester
AbbVie
Hoffmann-La Roche
SecuraBio
SecuraBio
AbbVie
TG Therapeutics, Inc.
Celgene
Novartis
Alliance for Clinical Trials in Oncology
Gilead Sciences
Janssen Research & Development, LLC
Pharmacyclics LLC.
Hoffmann-La Roche
Fred Hutchinson Cancer Center
Gilead Sciences
Gilead Sciences
Celgene
Novartis
Gilead Sciences
Gilead Sciences
Gilead Sciences
Gilead Sciences
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche
Pharmacyclics LLC.
Lundbeck Canada Inc.
Hoffmann-La Roche
Vanderbilt-Ingram Cancer Center
Alliance for Clinical Trials in Oncology
US Oncology Research
Sanofi
INSYS Therapeutics Inc
Hoffmann-La Roche
Fred Hutchinson Cancer Center